Human medicines European public assessment report (EPAR): Buprenorphine Neuraxpharm, buprenorphine, Date of authorisation: 19/12/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Sibnayal, potassium citrate,potassium hydrogen carbonate, Date of authorisation: 30/04/2021, Revision: 3, Status: Authorised
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-15 May 2025
Summary of opinion: Bluevac BTV (previously Bluevac BTV8), 15/05/2025 Positive
Summary of opinion: Stronghold Plus, 15/05/2025 Positive
Summary of opinion: NexGard Combo, 15/05/2025 Positive
Human medicines European public assessment report (EPAR): Cerdelga, eliglustat, Date of authorisation: 19/01/2015, Revision: 20, Status: Authorised
Human medicines European public assessment report (EPAR): Bortezomib Hospira, bortezomib, Date of authorisation: 22/07/2016, Revision: 14, Status: Authorised
Human medicines European public assessment report (EPAR): Fingolimod Accord, fingolimod, Date of authorisation: 25/06/2020, Revision: 9, Status: Authorised
EVVET – Data warehouse user manual